Reduces appetite: This medication reduces your appetite by sending signals of fullness to your brain, lowering the hunger stimulation hormone, and delaying gastric emptying
Specifically, glucagon-like peptide 1 receptor agonists (arGLP-1), such as semaglutide, have demonstrated a mean weight loss approaching the 15% threshold [18,19,20]
The type 2 diabetes segment dominated the market in 2024, owing to the longstanding clinical use of GLP-1 drugs in glycemic control and the growing emphasis on cardiovascular and renal benefits
As semaglutide gains popularity, both patients and healthcare providers must work together to navigate the complexities of its various formulations
GLP-1 receptor activation can reduce neuroinflammation and oxidative stress, and restore insulin signaling, which may compensate for the dysfunctional dopaminergic neurotransmission and motor deficits associated with PD pathogenesis [74, 75]
never in the regular trash